Percutaneous patent foramen ovale closure: Outcomes with the Premere and Amplatzer devices

Cardiovascular Revascularization Medicine

Volumn 12, Issue 3, 2011, Pages 164-169

  Bissessor, Naylin ^a,b,c,d   Wong, Allison W ^d   Hourigan, Lisa A ^a   Jayasinghe, Rohan S ^b,c   Scalia, Greg S ^a   Burstow, Darryl J ^a   Griffiths, Lyn R ^c   Savage, Michael ^a   Walters, Darren L ^a  

^a THE PRINCE CHARLES HOSPITAL   (Australia)

^b GOLD COAST UNIVERSITY HOSPITAL   (Australia)

^c GRIFFITH UNIVERSITY   (Australia)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Closure devices, Stroke; PFO; Transcatheter closure

Indexed keywords

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; DATA BASE; DECOMPRESSION SICKNESS; ECHOCARDIOGRAPHY; EMBOLISM; FEMALE; FOLLOW UP; HEART CATHETER; HEART RIGHT LEFT SHUNT; HEART SURGERY; HEMATOMA; HUMAN; INTRACARDIAC ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIGRAINE; PATENT FORAMEN OVALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPTAL OCCLUDER; SKIN INFECTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; AGED; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EMBOLISM, PARADOXICAL; FEMALE; FORAMEN OVALE, PATENT; HEART CATHETERIZATION; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; QUEENSLAND; RECURRENCE; SEPTAL OCCLUDER DEVICE; STROKE; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL; YOUNG ADULT;

EID: 79957839396     PISSN: 15538389     EISSN: 18780938     Source Type: Journal    
DOI: 10.1016/j.carrev.2010.06.001     Document Type: Article

References (20)

1. Windecker S, Wahl A, Chatterjee T, et al. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: Long term risk of recurrent thromboembolic events. Circulation 2000, 101:893-898.
2. Hagen PT, Scholz DG, Edwards WD Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984, 59:17-20.
3. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics-2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119(3):480-486.
4. Tobis MJ, Azarbal B Does patent foramen ovale promote cryptogenic stroke and migraine headache?. Tex Heart Inst J 2005, 32(3):362-365.
5. Varma C, Benson LN, Warr MR, et al. Clinical outcomes of patent foramen ovale closure for paradoxical emboli without echocardiographic guidance. Catheter Cardiovasc Interv 2004, 62:519-525.
6. Schwerzmann M, Windecker S, Wahl A, et al. Percutaneous closure of patent foramen ovale: Impact of device design on safety and efficacy. Heart 2004, 90:186-190.
7. Taaffe M, Fischer E, Baranowski A, et al. Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARflex versus Helex occluder). Am J Cardiol 2008, 101(9):1353-1358. Epub 2008 Mar 10.
8. Alibegovic J, Bonvini R, Sigwart U, et al. The role of the sizing balloon in selection of the patent foramen ovale closure device size. Exp Clin Cardol 2008, 13(1):42-46.
9. Woods TD, Patel A A critical review of patent foramen ovale detection using saline contrast echocardiography: when bubbles lie. J Am Soc Echocardiogr 2006, 19:215-222.
10. Gramiak R, Shah PM, Kramer DH Ultrasound cardiography: contrast studies in anatomy and function. Radiology 1969, 92:939-948.
11. Gill EA, Quaife RA The echocardiographer and the diagnosis of patent foramen ovale. Cardiol Clin 2005, 23:47-52.
12. Büscheck F, Sievert H, Kleber F, Tiefenbacher C, Krumsdorf U, Windecker S, Uhlemann F, Wahr DW Patent foramen ovale using the Premere device: the results of the CLOSEUP trial. JACC J Interv Cardiol 2006, 19(4):328-333.
13. Lamy C, Meder JF, Trystram D, Coste J, Mas JL Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA Study. Atrial Septal Aneurysm Stroke 2002, 33(3):706-711.
14. Dearani JA, Ugurlu BS, Danielson GK, Daly RC, McGregor CG, Mullany CJ, Puga FJ, Orszulak TA, Anderson BJ, Brown RD, Schaff HV Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation 1999, 100(19 Suppl):I171-II175.
15. Krasuski RA, Hart SA, Allen D, Qureshi A, Pettersson G, Houghtaling PL, Batizy LH, Blackstone E Prevalence and repair of intraoperatively diagnosed patent foramen ovale and association with perioperative outcomes and long-term survival. JAMA 2009, 302(3):290-297.
16. Wertman B, Azarbal B, Riedl M, Tobis J Adverse events associated with nickel allergy in patients undergoing percutaneous atrial septal defect or patent foramen ovale closure. J Am Coll Cardiol 2006, 47:1226-1227.
17. Nendaz MR, Sarasin FP, Junod AF, Bogousslavsky J Preventing stroke recurrence in patients with patent foramen ovale: antithrombotic therapy, foramen closure, or therapeutic abstention? A decision analytic perspective. Am Heart J 1998, 135:532-541.
18. Aslam F, Iliadis AE, Blankenship JC Percutaneous closure of patent foramen ovale: success and outcomes of a low-volume procedure at a rural medical center. J Invasive Cardiol 2007, 19:20-24.
19. Bruch L, Parsi A, Grad MO, et al. Transcatheter closure of interatrial communications for secondary prevention of paradoxical embolism: single center experience. Circulation 2002, 105:2845-2848.
20. Wahl A, Meier B, Haxel B, et al. Prognosis after percutaneous closure of patent foramen ovale for paradoxical embolism. Neurology 2001, 57:1330-1332.